These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 33339012)
1. Quantitative PET in the 2020s: a roadmap. Meikle SR; Sossi V; Roncali E; Cherry SR; Banati R; Mankoff D; Jones T; James M; Sutcliffe J; Ouyang J; Petibon Y; Ma C; El Fakhri G; Surti S; Karp JS; Badawi RD; Yamaya T; Akamatsu G; Schramm G; Rezaei A; Nuyts J; Fulton R; Kyme A; Lois C; Sari H; Price J; Boellaard R; Jeraj R; Bailey DL; Eslick E; Willowson KP; Dutta J Phys Med Biol; 2021 Mar; 66(6):06RM01. PubMed ID: 33339012 [TBL] [Abstract][Full Text] [Related]
2. Integrated whole-body PET/MR hybrid imaging: clinical experience. Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775 [TBL] [Abstract][Full Text] [Related]
3. Where to next prostate-specific membrane antigen PET imaging frontiers? Donswijk ML; Morigi JJ; Little A; Vogel WV; van Leeuwen PJ Curr Opin Urol; 2020 Sep; 30(5):672-678. PubMed ID: 32701718 [TBL] [Abstract][Full Text] [Related]
4. Development and experimental medicine applications of PET in oncology: a historical perspective. Jones T; Price P Lancet Oncol; 2012 Mar; 13(3):e116-25. PubMed ID: 22381934 [TBL] [Abstract][Full Text] [Related]
5. PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future. Basu S; Alavi A PET Clin; 2016 Jul; 11(3):203-7. PubMed ID: 27321025 [TBL] [Abstract][Full Text] [Related]
6. Deep learning for whole-body medical image generation. Schaefferkoetter J; Yan J; Moon S; Chan R; Ortega C; Metser U; Berlin A; Veit-Haibach P Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3817-3826. PubMed ID: 34021779 [TBL] [Abstract][Full Text] [Related]
7. Oncologic Applications of Long Axial Field-of-View PET/Computed Tomography. Nardo L; Pantel AR PET Clin; 2021 Jan; 16(1):65-73. PubMed ID: 33218605 [TBL] [Abstract][Full Text] [Related]
8. Novel Quantitative PET Techniques for Clinical Decision Support in Oncology. Zaidi H; Alavi A; Naqa IE Semin Nucl Med; 2018 Nov; 48(6):548-564. PubMed ID: 30322481 [TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images. Zaharchuk G; Davidzon G Semin Nucl Med; 2021 Mar; 51(2):134-142. PubMed ID: 33509370 [TBL] [Abstract][Full Text] [Related]
11. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970 [TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems. Vaquero JJ; Kinahan P Annu Rev Biomed Eng; 2015; 17():385-414. PubMed ID: 26643024 [TBL] [Abstract][Full Text] [Related]
13. What scans we will read: imaging instrumentation trends in clinical oncology. Beyer T; Bidaut L; Dickson J; Kachelriess M; Kiessling F; Leitgeb R; Ma J; Shiyam Sundar LK; Theek B; Mawlawi O Cancer Imaging; 2020 Jun; 20(1):38. PubMed ID: 32517801 [TBL] [Abstract][Full Text] [Related]
14. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer. Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449 [TBL] [Abstract][Full Text] [Related]
15. Feasibility study of a point-of-care positron emission tomography system with interactive imaging capability. Jiang J; Li K; Komarov S; O'Sullivan JA; Tai YC Med Phys; 2019 Apr; 46(4):1798-1813. PubMed ID: 30667069 [TBL] [Abstract][Full Text] [Related]
16. Advances in metabolic imaging for surgical oncology. Iagaru A; Quon A Surg Oncol Clin N Am; 2007 Apr; 16(2):273-92. PubMed ID: 17560512 [TBL] [Abstract][Full Text] [Related]
17. Improvement of attenuation correction in time-of-flight PET/MR imaging with a positron-emitting source. Mollet P; Keereman V; Bini J; Izquierdo-Garcia D; Fayad ZA; Vandenberghe S J Nucl Med; 2014 Feb; 55(2):329-36. PubMed ID: 24434291 [TBL] [Abstract][Full Text] [Related]
18. Towards enhanced PET quantification in clinical oncology. Zaidi H; Karakatsanis N Br J Radiol; 2018 Jan; 91(1081):20170508. PubMed ID: 29164924 [TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of dynamic PET imaging data in cancer imaging. Muzi M; O'Sullivan F; Mankoff DA; Doot RK; Pierce LA; Kurland BF; Linden HM; Kinahan PE Magn Reson Imaging; 2012 Nov; 30(9):1203-15. PubMed ID: 22819579 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]